Arrotex ups its game in biosimilars

By Megan Brodie 8 months ago | In Companies, Products
  • 8 months ago
Arrotex Specialty Brands and Biologics GM Matthew Donnison.

21 June 2023 Three in five patients that switch from AbbVie’s blockbuster immunology biologic HUMIRA…

This is subscriber-only content. Please login to continue reading.